UCP2-SIRT3信号缓解糖尿病视网膜病变中高血糖诱导的氧化应激与衰老
本研究通过人视网膜前膜标本和原代人视网膜微血管内皮细胞高糖模型,探究解偶联蛋白2(UCP2)在糖尿病视网膜病变(DR)中的作用及机制。结果显示DR患者增殖性纤维血管膜中UCP2与SIRT3表达下调,UCP2过表达可减轻高糖诱导的氧化应激和衰老,该保护作用依赖NAD+-SIRT3轴,3-TYP抑制SIRT3后保护效应消失。
要点
- DR患者增殖性纤维血管膜中UCP2和SIRT3表达下调。
- 腺病毒介导UCP2过表达可保护内皮细胞免受高糖诱导的氧化应激和衰老。
- UCP2过表达通过促进NAD+依赖的SIRT3表达和活性发挥保护作用,3-TYP可 abolishing 该效应。
核心结论
- UCP2过表达基于调控NAD+-SIRT3轴的新机制缓解氧化应激和衰老,UCP2-SIRT3信号可能作为DR及其他糖尿病血管疾病防治的方法。
研究设计与样本
- 收集人视网膜前膜,采用qRT-PCR和免疫荧光检测UCP2表达。
- 原代人视网膜微血管内皮细胞(HRECs)在高糖(HG)下培养建立DR体外细胞模型。
- 采用流式细胞术检测细胞内活性氧(ROS),SA-β-gal实验、衰老标志物P21表达和细胞周期分析评估衰老水平。
- 通过腺病毒介导UCP2过表达或敲低及特定抑制剂研究调控机制。
主要发现
- DR患者增殖性纤维血管膜经qRT-PCR和免疫荧光显示UCP2和SIRT3下调。
- 持续高血糖诱导DR进程中UCP2下调,腺病毒介导UCP2过表达保护内皮细胞免受高糖诱导的氧化应激和衰老。
- 高糖条件下UCP2过表达减弱NAD+下调,促进NAD+依赖性去乙酰化酶SIRT3的表达和活性。
- 选择性SIRT3抑制剂3-TYP消除了UCP2介导的抗氧化应激和抗衰老保护效应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Diabetic retinopathy (DR) is one of the most common reasons for blindness. uncoupling protein 2 (UCP2), an uncoupling protein located in mitochondria, has been reported to be related to metabolic and vascular diseases. This research aimed to illustrate the function and mechanism of UCP2 in the pathogenesis of DR. METHODS: Human epiretinal membranes were collected to investigate the expression of UCP2 by quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence. Primary human retinal microvascular endothelial cells (HRECs) were cultured in high glucose (HG) to establish an in vitro cell model for DR. Flow cytometry analysis was used to measure intracellular reactive oxygen species (ROS). Senescence levels were evaluated by the senescence-associated beta-galactosidase (SA-β-gal) assay, the expression of senescence marker P21, and cell-cycle analysis. Adenovirus-mediated UCP2 overexpression or knockdown and specific inhibitors were administered to investigate the underlying regulatory mechanism. RESULTS: Proliferative fibrovascular membranes from patients with DR illustrated the downregulation of UCP2 and sirtuin 3 (SIRT3) by qRT-PCR and immunofluorescence. Persistent hyperglycemia-induced UCP2 downregulation in the progress of DR and adenovirus-mediated UCP2 overexpression protected endothelial cells from hyperglycemia-induced oxidative stress and senescence. Under hyperglycemic conditions, UCP2 overexpression attenuated NAD+ downregulation; hence, it promoted the expression and activity of SIRT3, an NAD+-dependent deacetylase regulating mitochondrial function. 3-TYP, a selective SIRT3 inhibitor, abolished the UCP2-mediated protective effect against oxidative stress and senescence. CONCLUSIONS: UCP2 overexpression relieved oxidative stress and senescence based on a novel mechanism whereby UCP2 can regulate the NAD+-SIRT3 axis. Targeting oxidative stress and senescence amelioration, UCP2-SIRT3 signaling may serve as a method for the prevention and treatment of DR and other diabetic vascular diseases.
引用
- Li S, Sun D, Chen S, et al. UCP2-SIRT3 Signaling Relieved Hyperglycemia-Induced Oxidative Stress and Senescence in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2024. PMID: 38175638. doi:10.1167/iovs.65.1.14
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。